Home | Articles
Published on:January 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(1s):s81-s88
Original Article | doi:10.5530/ijper.56.1s.46

Protective Effects of Silymarin and/or Omega-3 Fatty Acids against Paracetamol-initiated Liver Toxicity in Rats


Authors and affiliation (s):

Rajesh A. Maheshwari1,*, Divya Khemani1, Ashim Kumar Sen1, Ramachandran Balaraman1, Ramaswamy Velmurugan2, Dhanya B. Sen1

1Department of Pharmacy, Sumandeep Vidyapeeth (Deemed to be University), Piparia, Waghodia, Vadodara, Gujarat, INDIA.

2Drug Discovery R&D, Century Pharmaceutical Limited, Vadodara, Gujarat, INDIA.

Abstract:

Background and Aim: The proposed experiment was planned to evaluate the potential protective function of aqueous extract of Silymarin (SL) concentrate and/or Omega-3 fatty acids (O3FAs) against PCM-initiated liver toxicity in rats. Materials and Methods: Thirty Wistar-albino rats (either of sex) were distributed among five equivalent groups as follows: Normal control group, PCM control group, PCM + SL group (25 mg/kg, p.o.), PCM + O3FAs group (300 mg/kg, p.o.), PCM + SL + O3FAs group. All the treatments were administered for 14 days. Hepatotoxicity was induced in all groups except Group I by injection of PCM (2 g/kg, i.p.) on 14th day post the administration of drugs. Results: Noticeable rise in the levels of AST, ALT, ALP, total bilirubin, direct bilirubin, MDA, TNF-α, IL-6, VEGF and CRP were seen alongside a substantial reduction in the levels of serum total protein content and antioxidant enzymes, SOD, GSH, catalase in PCM control group. Treatment with SL or O3FAs or SL + O3FAs exhibited a considerable alteration in abovementioned biomarkers. Conclusion: The study concluded that SL and/or O3FAs protected the liver against PCM-initiated liver toxicity. However, the significantly increased hepatoprotective effects of SL when combined with O3FAs insinuate a possible synergism.

Key words: Silymarin, Omega-3 fatty acids, TNF-α, IL-6, VEGF, CRP.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs